Health Care Equipment and Supplies Health Care Equipment

More

  • Beijing issues second smog red alert for December Friday, 18 Dec 2015 | 1:05 AM ET
    Visitors walk on a bridge as they visits the West Lake amid thick fog and heavy smog in Hangzhou, Zhejiang province, China, December 8, 2015.

    China's capital Beijing issued its second smog red alert of the month on Friday, triggering vehicle restrictions and forcing schools to close.

  • Dec 3- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped by higher sales in all divisions. The Dublin- based company said adjusted profit per share included a 4- cent charge from integrating Covidien Plc, which Medtronic bought in January for nearly $50 billion. Medtronic said its net profit fell to $520 million, or 36...

  • Medical device maker Medtronic's revenue jumps 62 pct Thursday, 3 Dec 2015 | 6:55 AM ET

    Dec 3- Medical device maker Medtronic Plc reported a 62 percent jump in quarterly revenue, helped by higher sales in all divisions. The Dublin- based company's net profit fell to $520 million, or 36 cents per share, in the second quarter ended Oct. 30 from $828 million, or 83 cents per share, a year earlier, mainly due to higher restructuring charges.

  • Medtronic Plc, Abbott Laboratories, Edwards Lifesciences Corp and HeartWare International Inc in recent months have spent a total of $2 billion to buy young companies developing versions of the technology. Nearly 6 million people in the United States may suffer from mitral disease, and Wall Street analysts say it could be the next multibillion-dollar...

  • Rising demand for IVF in China will strain already-crowded state-run hospitals but create opportunities for overseas health centers.

  • PARIS, Nov 13- French medical technology company Mauna Kea could sign a partnership by the end of the year that would allow it to accelerate the commercial development of a small microscope approved by U.S. regulators for use in surgical procedures to diagnose cancer, its chief executive told Reuters. According to Mauna Kea, the use of Cellvizio in surgery would...

  • In its letter, posted on Monday, the agency said it was unable to identify any FDA clearance for the company's test. In a statement sent to Reuters last week, FDA spokesman Eric Pahon said the FDA believes that "certain types of tests are being appropriately offered through the DTC model, but others may need to demonstrate that they are safe and effective and that...

  • Nov 6- Indiana- based medical device manufacturer Zimmer Biomet Holdings Inc on Friday was cleared of liability in the first of more than 900 U.S. lawsuits to go to trial over claims that its NexGen Flex knee replacements were prone to painful, motion-impairing loosening. Following a three-week trial in the U.S. District Court for the Northern District of...

  • Baxter names former Covidien chief Jos+¬ Almeida CEO Wednesday, 28 Oct 2015 | 5:33 PM ET

    Oct 28- Hospital products maker Baxter International said it named José Almeida chief executive officer, succeeding Robert Parkinson, who retires on Jan. 1. Almeida was previously chief executive of Covidien Plc, which was acquired by medical device maker Medtronic Plc in January this year. The Wall Street Journal earlier on Wednesday reported that the...

  • Oct 28- Medical device maker Boston Scientific Corp reported a better-than-expected quarterly profit, helped by strong demand for its surgical products. Boston Scientific's MedSurg unit- which makes surgical products, excluding those for the heart- notched sales growth of 17.5 percent in the quarter. Boston Scientific said total revenue increased 9...

  • Boston Scientific's revenue rises about 2 pct Wednesday, 28 Oct 2015 | 6:44 AM ET

    Oct 28- Medical device maker Boston Scientific Corp reported a 2.3 percent rise in quarterly revenue as sales rose in all three of its divisions. The company posted a net loss of $198 million, or 15 cents per share, in the third quarter ended Sept. 30, compared with net profit of $43 million, or 3 cents per share, a year earlier. Revenue rose to $1.89 billion from $1.85...

  • Oct 27- The U.S. Food and Drug Administration said privately held laboratory operator Theranos had been shipping a blood testing device under a wrong classification that exempted the product from regulatory control. The FDA said the "uncleared medical device" was shipped across California, Arizona and Pennsylvania. So far, the healthcare startup has FDA...

  • The announcement is a major step for the company, which in 2013 was ordered by the FDA to stop selling its Personal Genome Service because the regulatory agency had not approved the tests, which the company was offering directly to consumers. The relaunched service will offer FDA- approved tests that show whether an individual carries genes associated with 36...

  • Theranos uses key technology in just one test: WSJ Friday, 16 Oct 2015 | 12:07 AM ET

    Theranos only uses its finger-prick technology in one test after pressure from regulators, The WSJ reports.

  • St Jude Medical gets warning letter from FDA Friday, 2 Oct 2015 | 5:48 PM ET

    Oct 2- Medical device maker St Jude Medical Inc said it had received a warning letter from the U.S. Food and Drug Administration related to "some non-conformities" observed from its manufacturing facility in Atlanta, Georgia.

  • Why UPS and FedEx may matter to your health Friday, 2 Oct 2015 | 11:26 AM ET
    Inside UPS's logistics facility in Swedesboro, New Jersey.

    As baby boomers age, UPS, FedEx and DHL expect health-care logistics to become a more important part of their future.

  • In an Aug. 31 filing in federal court in Toledo, Ohio, the defendant asked the court to compel MedStar to turn over more information about the liens, so it can investigate whether the funder schemed to "artificially inflate damages claims." According to DePuy, MedStar submitted claims for nearly $1.5 million for 11 surgeries that should have cost no more than...

  • LONDON, Sept 23- Sales of silicone implants made by Brazil's Silimed and used in thousands of patients in Britain have been suspended due to safety concerns, British medical regulators and suppliers said on Thursday. Silimed says it is the largest manufacturer of silicone implants in South America, first in sales in Brazil and third in the world.

  • LONDON, Sept 23- Britain's health regulator has suspended sales of silicone implants made by Brazil's Silimed due to contamination, and recommends none of the devices- including breast, penile and testicular implants- be used until further notice. The Medicines and Healthcare Products Regulatory Agency said it and other European regulators are testing...

  • Sept 23- UK's health regulator suspended the sales of silicone implants made by Brazil's Silimed and recommended that none of the devices be implanted until further advice. Medicines and Healthcare Products Regulatory Agency and other European regulators are testing the products after the German Notified Body found contamination on some devices during...